Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.08 USD | -6.09% | -23.94% | -6.90% |
Business Summary
Number of employees: 18
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
New Drugs and Medical Devices
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -84.28% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -84.28% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 23/23/23 | |
Leeds Chow
DFI | Director of Finance/CFO | 35 | 01/21/01 |
Eugene Jiang
CHM | Chairman | 38 | 01/15/01 |
Chief Tech/Sci/R&D Officer | 70 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yue Min Chung
BRD | Director/Board Member | 59 | 10/22/10 |
Shu Ling Chiang
BRD | Director/Board Member | 68 | - |
Eugene Jiang
CHM | Chairman | 38 | 01/15/01 |
Tsang Ming Jiang
BRD | Director/Board Member | 63 | 23/17/23 |
Norimi Sakamoto
BRD | Director/Board Member | 53 | 23/17/23 |
Yen-Hsin Chou
BRD | Director/Board Member | 43 | 23/17/23 |
Chief Tech/Sci/R&D Officer | 70 | - | |
Chang-Jen Jiang
BRD | Director/Board Member | 68 | - |
Yoshinobu Odaira
BRD | Director/Board Member | 76 | - |
Che-Wei Hsu
BRD | Director/Board Member | 43 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,560,421 | 7,711,924 ( 73.03 %) | 0 | 73.03 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-6.90% | 11.38M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |
- Stock Market
- Equities
- ABVC Stock
- Company ABVC BioPharma, Inc.